- Potential benefitRaises public and clinical awareness of PSP, potentially improving recognition and referrals.
- Potential benefitSignals Congressional recognition that may encourage researchers and funders to prioritize PSP studies.
- Potential benefitMay increase fundraising and philanthropic donations for PSP organizations and research efforts.
Expressing support for the designation of the month of May 2025 as "Progressive Supranuclear Palsy Awareness Month".
Referred to the House Committee on Energy and Commerce.
This resolution expresses the House of Representatives' support for designating May 2025 as Progressive Supranuclear Palsy Awareness Month. It is a non-binding statement by one chamber and does not create law or require the President's approval. The text encourages awareness, research, support services, and better care for people affected by the disease. It also recognizes and commends researchers, caregivers, organizations, and families working on PSP.
This House resolution expresses support for designating May 2025 as "Progressive Supranuclear Palsy Awareness Month." It describes PSP’s symptoms, prevalence estimates, lack of disease-modifying treatments, and the need for research, support services, and education.
The resolution affirms support for awareness goals, research toward treatments and a cure, and commends researchers, volunteers, families, and organizations.
It is a non‑binding, symbolic statement and does not authorize funding or regulatory changes.
As a House simple resolution it does not become law; adoption by the House is likely but statutory enactment requires additional, unlikely steps.
Relative to its intended legislative type, this bill is a straightforward commemorative House resolution that clearly defines the health condition it highlights and appropriately limits itself to expressing support for an awareness month and related goals.
All support awareness; liberals push for funding, conservatives stress no new spending
Who stands to gain, and who may push back.
These are examples from the analysis, not a ranked list of the most-affected groups.
- Federal agenciesCreates no new federal funding, legal authority, or entitlement for PSP research or care.
- Potential burdenIs symbolic only and may create public expectations without delivering concrete services or support.
- Potential burdenUses Congressional time for a nonbinding resolution that critics may view as low legislative priority.
Why the argument around this bill splits.
All support awareness; liberals push for funding, conservatives stress no new spending
Likely welcomes the designation as an important step to spotlight a neglected neurodegenerative disease and to support patients, caregivers, and research.
Would view the resolution positively but note it’s symbolic without explicit funding or policy actions.
Views the resolution as a low‑cost, bipartisan acknowledgement that can help patients and researchers.
Sees it as sensible but incomplete without specific implementation or funding mechanisms.
Likely accepts the resolution as harmless recognition of a disease and supportive of families and researchers, while emphasizing limited federal action.
Prefers private-sector and state-led solutions over new federal spending.
The path through Congress.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
As a House simple resolution it does not become law; adoption by the House is likely but statutory enactment requires additional, unlikely steps.
- Whether the House will schedule the resolution for floor consideration
- Existence or prospect of a companion Senate resolution
Recent votes on the bill.
No vote history yet
The bill has not accumulated any surfaced votes yet.
Go deeper than the headline read.
All support awareness; liberals push for funding, conservatives stress no new spending
As a House simple resolution it does not become law; adoption by the House is likely but statutory enactment requires additional, unlikely…
Relative to its intended legislative type, this bill is a straightforward commemorative House resolution that clearly defines the health condition it highlights and appropriately limits itself to expressing support for…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.